258 related articles for article (PubMed ID: 28358263)
1. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.
Wang Q; Zhang W; Hao S
Cell Cycle; 2017 Apr; 16(8):795-801. PubMed ID: 28358263
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.
Chen L; Hu N; Wang C; Zhao H; Gu Y
Cell Cycle; 2018; 17(3):319-329. PubMed ID: 29228867
[TBL] [Abstract][Full Text] [Related]
5. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
[TBL] [Abstract][Full Text] [Related]
6. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
7. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
8. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression.
Shang A; Wang W; Gu C; Chen W; Lu W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8301-8320. PubMed ID: 32380476
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
Shen Z; Wu Y; He G
Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
[TBL] [Abstract][Full Text] [Related]
11. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
Hu X; Jiang H; Jiang X
Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA long intergenic non-protein-coding RNA 173 contributes to nasopharyngeal carcinoma progression by regulating microRNA-765/Gremlin 1 pathway.
Wang D; Jiang H
Hum Exp Toxicol; 2023; 42():9603271231172921. PubMed ID: 37365917
[TBL] [Abstract][Full Text] [Related]
14. LINC00114 promoted nasopharyngeal carcinoma progression and radioresistance in vitro and in vivo through regulating ERK/JNK signaling pathway via targeting miR-203.
Han YY; Liu K; Xie J; Li F; Wang Y; Yan B
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2491-2504. PubMed ID: 32196600
[TBL] [Abstract][Full Text] [Related]
15. lncRNA CASC2/miR‑18a‑5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8.
Miao WJ; Yuan DJ; Zhang GZ; Liu Q; Ma HM; Jin QQ
Oncol Rep; 2019 Mar; 41(3):1797-1806. PubMed ID: 30569153
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
Hu W; Li H; Wang S
BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 promotes nasopharyngeal carcinoma development via targeting miR-424-5p.
Zhou Z; Chen Y
Histol Histopathol; 2023 Aug; 38(8):953-963. PubMed ID: 36727428
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CCAT1 promotes autophagy via regulating ATG7 by sponging miR-181 in hepatocellular carcinoma.
Guo J; Ma Y; Peng X; Jin H; Liu J
J Cell Biochem; 2019 Oct; 120(10):17975-17983. PubMed ID: 31218739
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis.
Liu D; Wang Y; Zhao Y; Gu X
BMC Cancer; 2020 Mar; 20(1):178. PubMed ID: 32131767
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.
Jiang N; Zhao L; Zong D; Yin L; Wu L; Chen C; Song X; Zhang Q; Jiang X; He X; Feng J
Bioengineered; 2021 Dec; 12(2):10716-10728. PubMed ID: 34738862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]